Development of therapeutics for treating debilitating ophthalmic diseases.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2009 | SQUIRE PATTON BOGGS |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination (No Activity) |
— | |
| 2009 | SQUIRE PATTON BOGGS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | |
| 2009 | SQUIRE PATTON BOGGS |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| SQUIRE PATTON BOGGS | 3 | — |
| Issue | Activities |
|---|---|
| Budget/Appropriations | 2 |
| Pharmacy | 2 |
| Health Issues | 2 |